Open access peer-reviewed chapter

Elucidating the Complex Interrelationship on Early Interactions between Leishmania and Macrophages

Written By

Patrícia Sampaio Tavares Veras, Thiago Castro-Gomes and Juliana Perrone Bezerra de Menezes

Submitted: 16 February 2022 Reviewed: 18 May 2022 Published: 23 June 2022

DOI: 10.5772/intechopen.105468

From the Edited Volume

Macrophages - Celebrating 140 Years of Discovery

Edited by Vijay Kumar

Chapter metrics overview

210 Chapter Downloads

View Full Metrics

Abstract

The host’s ability to eradicate or control infection caused by intracellular pathogens depends on early interactions between these microorganisms and host cells. These events are related to the organism’s nature and stage of development and host immune status. Pathogens are recognized by host cells, which respond to infection by either mounting an efficient response or becoming a replication niche. Early interactions between the protozoan Leishmania parasite and host cell receptors activate different signaling pathways that can result in microbe elimination or, alternatively, infection establishment and the migration of Leishmania infected cells to other host tissues. This chapter focuses on Leishmania-macrophage interaction via phagocytosis, which involves a range of parasite ligands characteristic of Leishmania species and parasite stage of development and diverse host cell receptors. We also discuss alternative Leishmania entry by cell invasion and review how Leishmania spp. survive and replicate within the phagocytic compartment they induce.

Keywords

  • Leishmania spp.
  • early interactions
  • parasite survival
  • macrophage
  • phagocytosis

1. Introduction

Leishmaniasis is a wide-ranging group of diseases caused by different species of Leishmania parasites that result in a broad spectrum of clinical manifestations. Cutaneous leishmaniasis (CL) is characterized by skin and mucosal lesions. At the same time, Visceral leishmaniasis (VL) affects internal organs, such as the liver, spleen, and bone marrow, which can be fatal if left untreated [1]. The WHO has estimated that 30,000 new cases of VL and more than 1 million new cases of CL occur annually, with more than one billion people at risk of infection worldwide [2].

Clinical manifestations of Leishmaniasis are dependent on the infecting parasite species and host immune response [3]. The host’s ability to eradicate or control infection caused by intracellular pathogens depends on early interactions between these microorganisms and host cells. Firstly, pathogens are recognized by host cells, which either respond to infection by mounting an efficient response or becoming a replication niche. Early interactions between the protozoan Leishmania parasite and host cell receptors result in microbe elimination or infection establishment and the migration of Leishmania infected cells to other host tissues. The dissemination of infected cells containing Leishmania is crucial to parasite survival and infection in the vertebrate host [4].

Macrophages are crucial in the host response to Leishmania infection since these cells are considered the primary host cell for Leishmania parasites [5]. This chapter focuses on Leishmania–macrophage interaction via phagocytosis, which involves a range of parasite ligands characteristic of Leishmania species and parasite stage of development and diverse host cell receptors. We also discuss alternative Leishmania entry by cell invasion and how Leishmania parasites survive and replicate within the phagocytic compartment they induce and macrophage’s effector mechanisms and parasite killing.

Advertisement

2. General aspects of phagocytosis

Phagocytosis is a metabolism-dependent process involving the internalization of particulate material (>0.5 mm) by professional and non-professional phagocytes that can differentiate self from non-self, modified or damaged self-particles. It occurs in a series of distinct and complementary steps [6, 7]. Initially, when the phagocyte recognizes ligands of the particulate material by receptors on cellular membranes, occurs an increase in phosphatidyl bisphosphate (PIP2) levels, followed by a reduction in PIP2 mediated by the conversion of PIP2 to phosphatidyl triphosphate (PIP3) [8]. Next, PLCγ hydrolyzes PIP3 into diacylglycerol and inositol triphosphate (IP3) [9]. After the phagosome formation, maturation of this compartment by the acquisition of different proteins begins [10]. The parasite can promote changes in the kinetics of recruitment to the membrane and activation of these molecules, interfering with phagosome maturation and the microbicidal activity of macrophages [11].

The best-known receptors that induce the attachment and ingestion of different particles, opsonized or not, are those for the complement fractions (CR1 and CR3), those for the Fc region of antibodies (Fc RI, RII, and RIII), as well as the mannose and beta-glycan receptors involved in the recognition and phagocytosis of particles derived from yeast [12] or by circulating collectins and pentraxins [13]. In addition, microbial products defined by Medzhitov and Janeway in 1997 [14] as “pathogen-associated molecular patterns” (PAMPs) are recognized by pattern recognition receptors (PRRs), mainly the toll-like receptors (TLRs) [15] nod-like receptors [16] and dendritic cell receptors such as C-type lectins [17, 18]. The PRRs interplay between innate and adaptive immune responses by directly activating effector mechanisms and alerting the host organism to the presence of infectious agents, including the expression of a group of endogenous signals, such as inflammatory cytokines and chemokines [14, 19].

Like professional phagocytes, nonprofessional phagocytic cells have the machinery, cytoskeleton, and components for signal transduction necessary for phagocytosis [20]. Although intestinal epithelial cells and many nonprofessional cell lines phagocytose bacteria such as Shigella, Yersinia, and E. coli, the mechanisms involved in pathogen recognition by these nonprofessional phagocytes are less well-known than those by professional cells [21, 22]. The significant difference between the two types of phagocytes may be the presence of a broader spectrum and a more substantial number of receptors capable of performing phagocytosis on the membrane of professional cells [20, 23, 24, 25].

The molecular processes involved in the uptake of particulate material have been well studied using particles opsonized by immunoglobulins (Ig) class G (IgG) and cells expressing a receptor for the Fc region of IgGs. This interaction results in the clustering of ligand-associated receptors on the phagocytic cell surface. The signaling steps leading to IgG engulfment of opsonized particles are also well studied. These steps comprise the recruitment and activation of kinases, phosphorylation of the cytosolic portion of the receptor, and stimulation of GTPases of the Rac and Cdc42 families, which cooperate with phosphatidyl bisphosphate promoting the stabilization of WASP family proteins. In turn, the WASP protein activates the Arp2/3 complex, promoting actin filaments polymerization, followed by the emission of pseudopodia around the particle [26]. The phagocytosed agent will be internalized in a vesicle called a phagosome. The phagosome will then fuse with lysosomes, forming the phagolysosome. Phagocytosis depends on a complex network of vesicle trafficking pathways that interconnect most intracellular compartments linked to the membrane and actin cytoskeleton and requires the use of a large amount of plasma membrane for pseudopod extension around the target particle [27].

Advertisement

3. Phagosome biogenesis

By analogy with the flow of substances through the endocytic pathway, it is most likely that the ligands present on the surface of particles or microorganisms contribute to the determination of particle destiny within the cell [28, 29]. In addition, the particles and microorganisms’ composition present in vacuoles determines both the nature of the vacuolar contents [30, 31] and the ability of the organelles to fuse with other vesicles of the endocytic pathway [32, 33].

Newly formed phagosomes undergo a maturation process from the plasma membrane, which comprises a series of modifications, usually leading to the internalized particle’s degradation [6]. In the past, biochemical analyses have been performed on phagosomes isolated and purified at different time points after uptake by antibody-fixed and antibody-coated staphylococcus aureus present in J774 macrophages. These studies revealed that changes in the protein composition of phagosomes are similar to those already identified during endosome maturation or for compartments successively formed during the internalization of soluble components. Identical to the maturation process of endosome compartments, the protein content within phagosomes is partly recycled and sorted. These organelles, probably by fusion with pre-lysosomes, produce a final compartment that presents at the membrane lysosomal glycoproteins, mannose-6 phosphate receptors, and the ATP-dependent proton pump [29]. The maturation of phagosomes containing IgG-opsonized particles has already been well described for the recognition process. This process involves the remodeling of membranes, gaining and losing proteins, and lipid markers during their biogenesis. These steps comprise acquisition of Rab5 with the participation of Rab20 [34]; acquisition of proton pump V-ATPases, with the release of protons in the phagosomes and acidification of the intracellular medium [35]; conversion of the membrane of the initial phagosome into a late one, due to the recruitment of some proteins such as Mon1-Ccz1 by Rab5, which by the action of guanine exchange factor (GEF) recruit and activate Rab7. The formation of phagolysosomes culminates in the fusion between late phagosomes with lysosomes [36, 37].

Advertisement

4. Host cell and Leishmania interactions during phagocytosis - binding molecules and internalization process

The contact of promastigote forms of Leishmania spp. with different cell types, such as neutrophils, dendritic cells, and mainly macrophages, when entering the vertebrate host organism and some cells of the immune system will play an essential role in the development of the disease. The role of different cells, immune or not, at each stage of the infection remains controversial; however, it is possible to state that the parasites are mostly confined within macrophages in the chronic phase of Leishmaniasis. Regarding the cell invasion mechanism employed by the promastigote forms inoculated by the insect vector, it is believed that the main route of penetration into the host cell occurs by phagocytosis. Once phagocytosed, the parasite travels through the host cell endosomal pathway and not only survives but also replicates inside acidic parasitophorous vacuoles that fuse with host cell lysosomes [38, 39, 40].

The first studies showing the interaction of infective promastigotes with macrophages were carried out in the 70s [41] and focused on the observation of the interaction of the parasite with its host cell from the very first moments of interaction until its complete internalization, passing by all intermediate stages of parasite uptake. These studies carried out using scanning electron microscopy also showed, in a pioneering way, that the phagocytosis seems to start preferentially by the tip of the parasite’s flagellum. Although parasites could be found being phagocytosed by the cell body, the flagellum appears to be the preferred portion to trigger the internalization process. The promastigote flagellum is an anterior structure, extremely active and motile, towards which the parasite moves its body. Interestingly, and due to these morphological characteristics, there is an increasing debate proposing that the promastigote flagellum is, in fact, a sensory structure and that it is probably the first portion of the parasite to interact with host cells. When macrophages were treated with cytochalasin-D, a potent phagocytosis inhibitor, about 75% of the infection was blocked [42].

Given that 25% of the cells continued to be infected even with the drug treatment, these data showed the importance of phagocytosis as a way of invasion. Furthermore, they pointed to alternative routes of infection yet to be explored. As discussed below, we now know that these parasites can penetrate cells also through non-phagocytic pathways.

The internalization process of the Leishmania parasite is partially orchestrated like Fc receptor-dependent phagocytosis, particularly those steps involving the recognition of molecules on parasite surface by classical phagocytosis receptors or PRRs on the host cell membrane. Promastigotes have a dense glycocalyx on their surface, mainly consisting of lipophosphoglycan (LPG) molecules, which have long carbohydrate chains with repeating phosphoglycan units that are attached to the membrane by glycophosphatidylinositol (GPI) and glycoinositol phospholipid (GIPL) anchors [43]. The 63 kDa glycoprotein (gp63) is also abundant on the surface of amastigotes and exhibits proteolytic activity. Studies show that gp63 degrades immunoglobulins, complement factors, and lysosomal proteins. Thus, LPG and gp63 molecules protect the parasite from lysis by complement [44] and are involved in the interaction of the parasite with macrophages [45, 46, 47]. In addition to the direct interaction with parasite surface molecules such as LPG, gp63, and CR3 [48] the interaction of Leishmania with the macrophage can happen indirectly with receptors for complement fractions, such as CR1 and CR3, after opsonization of the parasite with C3b and C3bi, respectively [49, 50, 51, 52, 53]. Additionally, CR1 and CR3 act cooperatively with various receptors present on the macrophage surface, promoting phagocytosis of different Leishmania species [49, 52, 53, 54]. Complement receptors can interact with receptors for the Fc portion of Ig (FcR) when opsonized by IgGs [55, 56, 57]. Alternatively, the receptor for mannose and CR3 may act together to bind and internalize L. donovani [50, 58, 59]. In addition, the receptor for fibronectin [60, 61], as well as CR4 [48] and the receptor for C-reactive protein [62], may jointly participate in the phagocytosis of promastigotes of various Leishmania species, such as L. donovani, L. mexicana, and L. infantum.

In addition to classical phagocytosis receptors, PRRs also participate in the interaction of Leishmania with macrophages, being involved not in parasite internalization but rather in macrophage activation [63] and control of parasite proliferation [64] These Leishmania-macrophage interacting receptors have an influence on phagocytosis steps following ligand-receptor binding, such as actin polymerization [65] production of microbicidal molecules [66, 67], and the formation of the parasitophorous vacuole [68]. Scavenger Receptors (SRs) are PRRs that are part of a protein family with multiple transmembrane domains involved in receptor-mediated endocytosis of polyanionic ligands, including LDL (low-density lipoproteins) [69]. MARCO (Macrophage Receptor with Collagenous Structure), a specific scavenger receptor of the SR-A family, has a collagenous structure, and SRCR (Scavenger Receptor Cysteine-Rich) domain has also been implicated in infection of L. major by macrophages in vitro and in vivo [70] (Figure 1).

Figure 1.

Binding of Leishmania during parasite phagocytosis by macrophages. This image depicts the recognition step of the Leishmania internalization process by phagocytes. Before being internalized, promastigotes presenting several surface molecules, such as LPG, GPI, GIPL, and GP63, are recognized by host cell surface molecules, including CR1, CR3, CR4, Fc gamma receptors (FcγRs), fibronectin receptor, and the scavenger receptors, SRCR and MARCO. Some of these receptors, such as FcgRs and fibronectin, only recognize opsonized parasites. Alternatively, CR3 can bind to opsonized and non-opsonized Leishmania. For clarity, the opsonization process is not illustrated in this image.

Advertisement

5. A non-phagocytic route of invasion for Leishmania spp.

The fact that Leishmania spp. infect phagocytic cells created the perception that these parasites have a passive role in their internalization process, needing only to survive after being actively captured by the phagocyte. However, several groups have already described the infection of non-phagocytic cells in vivo and in vitro [71, 72, 73, 74]. Thus, as mentioned before, treatment with phagocytosis blocking agents did not abolish infection since a considerable percentage of parasites end up internalized in macrophages even in the presence of such blockers [41]. Taken together, these data pointed to something that remained unexplored until very recently: parasites of the genus Leishmania are capable of penetrating host cells through mechanisms that are independent of the host cell cytoskeleton, thus by non-phagocytic means. Recently, this mechanism was elucidated using non-phagocytic cells as host cells and promastigote forms of the parasite. It was clearly demonstrated that L. amazonensis promastigotes actively induce cell invasion without any cytoskeleton activity, therefore, by a mechanism distinct from phagocytosis [75]. Similar to what was observed for Trypanosoma cruzi [76], the infection involves calcium signaling, recruitment, and exocytosis of lysosomes engaged in the process of plasma membrane repair and lysosome-triggered endocytosis. Briefly, when damaged, eukaryotic cells respond to repair the plasma membrane in a sequential process that involves calcium-dependent exocytosis of lysosomes and endocytosis of plasma membrane lesions [77]. Leishmania parasites use this endocytic process to invade host cells in a cytoskeleton-independent manner. In the presence of inhibitory drugs, for example, this is likely the pathway that allows promastigotes to penetrate macrophages even if they cannot phagocytose them. The study of non-phagocytic invasion by Leishmania spp. and the role of non-phagocytic host cells in maintaining the pathogen’s life cycle is a neglected aspect of the biology of these organisms with great potential yet to be explored. It is possible, for example, that different routes of infection play different roles in the intracellular destination of parasites, impacting their replication rates and their abilities to evade the immune response and manipulate their host cells.

Advertisement

6. Establishment of Leishmania within host cell intracellular compartments

Phagolysosome biogenesis, also known as phagosome maturation, is a highly regulated membrane traffic process essential for pathogen intracellular fate, survival or intracellular death and degradation, and antigen processing presentation by professional phagocytes [78, 79]. This maturation process results from sequential fusion events between phagosomes and compartments of the endocytic pathway. Classical cell biology studies have revealed several aspects of the biogenesis of Leishmania-induced parasitophorous vacuoles [80, 81, 82, 83]. To date, the mechanisms that explain the differences in morphological characteristics of parasitophorous vacuoles have not been fully elucidated. However, above all, the relationship between these morphological differences and the course of infection needs further investigation.

For pathogens that live in intracellular compartments, the process of phagosome maturation does not necessarily follow the steps described for other particles. Once internalized, several microorganisms, including protozoa and bacteria, are adapted to live at least one phase of their life cycle inside host cells. It has been described at least three strategies adopted by different pathogens to evade the defense mechanisms developed by the host following infection. Some microorganisms induce the formation of vacuoles that do not acidify [84]. Other pathogens are phagocytosed and settle in acidified compartments from which they then escape to live in the cytoplasm of the host cell. The last group is formed by organisms adapted to survive in the phagolysosomes of the host cell, which is the case of Leishmania parasites [84].

After being recognized by receptors in the host cell surface, Leishmania parasites are internalized by macrophages and settle inside structures known as parasitophorous vacuoles. Once inside the parasitophorous vacuoles, the parasites transform into amastigote forms with a rounded shape without apparent flagellum. Recently, Batista et al. (2021) [85] have comprehensively revised several aspects of the dependence of host cell machinery on the biogenesis of Leishmania- and T. cruzi-induced parasitophorous vacuoles. It is well known that Leishmania-induced parasitophorous vacuoles are acidic compartments containing lysosomal enzymes that have access to soluble markers of the endocytic pathway [5, 86, 87]. Indeed, these compartments are bounded by a membrane enriched by late endosome and lysosome markers, including Rab 7, macrosialin, LAMP-1, LAMP-2, vacuolar ATPase, and MHC class II molecules [88, 89, 90] (Figure 2). These data support the hypothesis that Leishmania-induced parasitophorous vacuoles exhibit characteristics of phagolysosomes [83, 90]. In addition, several other biomolecules, including lipids, proteins, and sialoglycoproteins, are exchanged by parasites and host cells following contact. One example is the identification of endoplasmic reticulum (ER) markers in the early steps of Leishmania-induced parasitophorous vacuole formation, indicating the participation of ER during phagosome membrane formation [91, 92].

Figure 2.

Model of the parasitophorous vacuole composition induced by Leishmania. This image illustrates a representative parasitophorous vacuole induced by Leishmania in macrophages. These compartments generated by Leishmania interact with the endocytic pathway and endoplasmic reticulum compartments. These compartments acquire by fusion markers from the late endosome and lysosome vesicles, such as Rab 7, macrosialin, LAMP-1, LAMP-2, vacuolar ATPase, Nramp1, SLC38A9, and MHC class II molecules. In addition, these compartments also acquire some molecules from host cell membrane, the integral membrane protein CD36, and the secretory pathway, including calnexin, SEC22b, and syntaxin 5.

Despite similar characteristics among Leishmania-induced vacuoles, the kinetics of their formation [89, 93] and the morphology of these parasite-containing compartments vary depending on the species and growth stage of Leishmania. It has been shown that, after phagocytosis of promastigotes of [90] L. donovani orL. major, the parasites localize in transient phagosomes with little ability to fuse with late endosomes [89]. This delay probably favors promastigote differentiation into amastigote forms if parasites settled within an acidic lysosomal enzyme-rich parasitophorous vacuole induced by L. donovani. Another possible mechanism involved in maturation delay by L. donovani-induced parasitophorous vacuole is the upregulation of Rab5a, an early endosome protein, along with the recruitment of its effector protein EEA1 [94]. In contrast, Rab5a and EEA1 are early recruited to L. amazonensis parasitophorous vacuole and then rapidly exchanged by late endosome and lysosome markers [95, 96]. On the other hand, after internalization, amastigotes of L. donovani, L. amazonensis, and L. mexicana are found in compartments that rapidly fuse with late compartments of the endocytic pathway, an environment in which parasites seem to be resistant [93, 97]. Another difference found to exist among parasite-induced parasitophorous vacuoles regards to their size. Despite L. major, L. infantum, and L. braziliensis living in tight vacuoles containing only one parasite inside [83], parasites from the Mexican complex are phagocytosed and settle in tight vacuoles that increase in size and become large parasitophorous vacuoles with a high number of parasites [80, 98, 99] (Figure 3). The usual large size of these parasitophorous vacuoles seems to be dependent on host cell factors, including lysosomal traffic regulator LYST/Beige [100] CD36 receptor [101] and V-ATPase subunit d isoform 2 (ATP6V0d2) [102] as recently revised by Bahia et al., 2021 [85]. Interestingly, the large size is shown to be related to infection success because in host cells lacking CD36 receptors, parasitophorous vacuoles are small in size, and parasite multiplication is impaired [101].

Figure 3.

Model of the parasitophorous vacuole induced by different Leishmania species. Shown here a representative image of a tight parasitophorous vacuoles containing only one parasite inside induced by L. major and L. donovani, and a large parasitophorous vacuole with a high number of parasites induced by L. amazonensis and L. mexicana.

Advertisement

7. Macrophage effector mechanisms, parasite replication and infection amplification

Once internalized within the parasitophorous vacuoles, the amastigotes multiply by binary fission, facilitating infection amplification, and persistence in the mammalian host (Figure 4). It is commonly assumed that amastigotes are released after host cell burst, which could be occasioned by the burden imposed by the unrestrained replication of the parasite. However, this is still an unproven hypothesis. Thus, the process of infection amplification during leishmaniasis is still a black box. Therefore, our knowledge about the mechanisms that lead to infection amplification during Leishmania infection is, in fact, quite limited. However, some crucial clues come from important observations made from in vivo experiments depicting the very first moments of the infectious process using mice and promastigotes of Leishmania major naturally transmitted to the mammalian model through the infective bite of the insect vector [38]. These experiments showed that just after promastigote inoculation, neutrophils are the first immune cells to reach the site of infection and phagocytose the parasite. It has been also demonstrated that the parasite could modulate neutrophil viability, which may delay or accelerate the host cell death through apoptosis [103, 104]. The modulation of neutrophil viability helps the survival of the parasites until their final targets and the macrophages. These cells reach the site of infection being attracted by different chemotactic factors such as MIP 1β, which stimulates the phagocytosis of infected apoptotic bodies [104]. Together with the macrophage recruitment, the inhibition of IL-12 secretion and the high secretion of IL-10 and TGF-β generate an anti-inflammatory environment, favoring the parasite’s survival. This process of initial neutrophil invasion followed by phagocytosis of these infected and apoptotic cells by macrophages is known as the “Trojan horse” mechanism [105, 106]. From all this, at least one major conclusion can be made: macrophages do not need to be initially infected by the promastigotes inoculated by the vector. They can instead get infected by the ingestion of apoptotic cells or apoptotic cell bodies containing viable amastigotes previously internalized within another cell type. This would be an interesting strategy for the parasite because apoptotic mechanisms do not trigger inflammation, as it would lead to a silent infection of macrophages, favoring parasite replication.

Figure 4.

Human macrophages infected by L. amazonensis. Cells were infected in vitro using parasites expressing a red fluorescent protein, host cell cytoskeleton (F-actin - green) was labeled by Alexa 488-conjugated phalloidin (life technologies), and nuclei were labeled by DAPI (blue). The images show macrophages harboring L. amazonensis amastigote forms (red). Original images kindly provided by Prof. Jane Lima-Santos from Universidade Estadual de Santa Cruz, Bahia, Brazil.

As mentioned earlier, cell disruption with the release of amastigotes into the extracellular environment has never been demonstrated despite being often assumed to be a mechanism of amastigote spread. On the other hand, it is entirely plausible to hypothesize that the amplification of infection in leishmaniasis occurs by the ingestion of apoptotic bodies of dead infected macrophages by new macrophages. This is even more logical if we consider that the clearance of dead cells is one of the leading roles these phagocytes play in tissue remodeling. This lack of knowledge about whether amastigotes are released extracellularly is also reflected in the few studies approaching cell invasion by free amastigotes [107, 108, 109].

Still, it is necessary to emphasize that other mechanisms have also been proposed regarding the infection amplification process. Leishmania amastigotes can be transferred cell to cell, from macrophage to macrophage, as already observed in in vitro studies [110]. Furthermore, other studies have shown that amastigotes can also be released by exocytosis of the parasite after the fusion of the parasitophorous vacuole membrane with host cell plasma membrane, thus without cell rupture [72]. Hence, several possibilities explain the spread of amastigotes and the amplification of infection during leishmaniasis, which do not involve the rupture of the parasitized cell. It is entirely plausible to hypothesize that these silent and non-necrotic pathways of infection amplification, without cell leakage or release of free amastigotes in the extracellular environment (which could be quickly cleared by immune effectors, such as the complement system) have been evolutionarily selected and are responsible for the susceptibility of macrophages to the infection and the amazing ability of Leishmania spp. to survive within the cell type that was supposed to kill them.

The dissemination of infected cells containing Leishmania is critical to parasite survival and the establishment of infection in the vertebrate host. Thus, the ability of Leishmania-infected host cells to migrate may be necessary for lesion distribution on the host and the dissemination of disease. As the main host cells for Leishmania, macrophages are crucial for the establishment of infection. However, the role played by these cells in parasite homing to specific tissues and how parasites modulate macrophage function is still poorly understood. Previously published work has shown that infection with Leishmania modulates phagocyte functions associated with cell migration [111, 112, 113, 114]. Some of these studies have shown that infection with different Leishmania species reduces macrophage adhesion, which could facilitate parasite dissemination in vivo [113, 114, 115]. However, other authors have demonstrated that infection with Leishmania impairs the ability of macrophages to migrate [3, 111]. In contrast with previous work, it has been shown that the modulation induced by Leishmania could depend on parasite species [116]. Thus, the modulation of macrophage migration induced by Leishmania, as well as impacts on parasite dissemination, remains unelucidated.

In leishmaniasis, macrophages function as a replicative niche for Leishmania parasites and work as anti-leishmanial effector cells, as immunoregulators, and as permissive host cells for the long-term survival of persistent parasites [117]. Parasite recognition by macrophages and priming by cytokines, such as IFN-γ, lead to the activation of the macrophage’s microbicide machinery and production of reactive species, especially superoxide by the multimeric enzyme NADPH oxidase and nitric oxide (NO) by inducible nitric oxide synthase (iNOS) [118]. These critical molecules are known to be involved in the macrophage-mediated innate host defense against Leishmania parasites. Previously published studies have demonstrated that the killing of different Leishmania species (e.g., L. major, L. donovani, L. braziliensis) in vitro depended on ROS production. In addition, several studies in mouse models have provided convincing evidence for the crucial role of NO in Leishmania parasite killing [39, 117]. However, although IFN-γ has been recognized as the key activator of the leishmanicidal activity of human macrophages, the importance of both iNOS expression and NO production remains controversial in humans [119, 120, 121]. Thus, to survive within the hostile environment of macrophages, Leishmania parasites have evolved different strategies to circumvent the antimicrobial mechanisms developed by these cells.

Advertisement

8. Conclusions

Undoubtedly, Leishmania spp. parasites have evolved a series of adaptations to be captured by macrophages and, instead of succumbing after internalization, they not only survive in the endocytic pathway but also replicate within the intracellular compartment where several other parasites would meet death [122]. The mechanism involved in parasite survival within macrophages and their dissemination in the vertebrate host is still poorly understood. Thus, further studies to dissect the mechanisms involved in the early steps of Leishmania-macrophage interaction are critical for the full understanding of Leishmania pathogenesis.

Advertisement

Acknowledgments

This work was supported by grants from the Bahia State Research Support Foundation (FAPESB) and FAPEMIG; PSTV holds a grant (305235/2019-2) from National Council for Scientific and Technological Development (CNPq). PSTV and JPBMF are professors from PGPAT and PGBSMI financed by Higher Education Personnel Council–Brazil (CAPES)—Finance Code 001.

We thank Prof. Jane Lima-Santos for kindly providing the infected macrophage image.

Advertisement

Conflict of interest

The authors deny the existence of any conflict of interest.

References

  1. 1. Podinovskaia M, Descoteaux A. Leishmania and the macrophage: A multifaceted interaction. Future Microbiology. 2015;10(1):111-129
  2. 2. World Health O. Control of the leishmaniases. World Health Organization Technical Report Series. 2010;949:xii-xiii, 1-xii-xiii186. back cover
  3. 3. de Menezes JP, Koushik A, Das S, Guven C, Siegel A, Laranjeira-Silva MF, et al. Leishmania infection inhibits macrophage motility by altering F-actin dynamics and the expression of adhesion complex proteins. Cellular Microbiology. 2017;19(3):e12668
  4. 4. Bogdan C, Rollinghoff M. The immune response to Leishmania: Mechanisms of parasite control and evasion. International Journal for Parasitology. 1998;28(1):121-134
  5. 5. Alexander J, Vickerman K. Fusion of host cell secondary lysosomes with the parasitophorous vacuoles of Leishmania mexicana-infected macrophages. The Journal of Protozoology. 1975;22(4):502-508
  6. 6. Kumar V. Phagocytosis: Phenotypically simple yet a mechanistically complex process. International Reviews of Immunology. 2020;118-150:32141349
  7. 7. Galli G, Saleh M. Immunometabolism of macrophages in bacterial infections. Frontiers in Cellular and Infection Microbiology. 2021;10:607650
  8. 8. Jaumouille V, Farkash Y, Jaqaman K, Das R, Lowell CA, Grinstein S. Actin cytoskeleton reorganization by Syk regulates Fcgamma receptor responsiveness by increasing its lateral mobility and clustering. Developmental Cell. 2014;29(5):534-546
  9. 9. Akashi K, Traver D, Miyamoto T, Weissman IL. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 2000;404(6774):193-197
  10. 10. Flannagan RS, Harrison RE, Yip CM, Jaqaman K, Grinstein S. Dynamic macrophage “probing” is required for the efficient capture of phagocytic targets. The Journal of Cell Biology. 2010;191(6):1205-1218
  11. 11. Haas A. The phagosome: Compartment with a license to kill. Traffic. 2007;8(4):311-330
  12. 12. Stahl PD, Ezekowitz RA. The mannose receptor is a pattern recognition receptor involved in host defense. Current Opinion in Immunology. 1998;10(1):50-55
  13. 13. Deban L, Jaillon S, Garlanda C, Bottazzi B, Mantovani A. Pentraxins in innate immunity: Lessons from PTX3. Cell and Tissue Research. 2011;343(1):237-249
  14. 14. Medzhitov R, Janeway CA Jr. Innate immunity: The virtues of a nonclonal system of recognition. Cell. 1997;91(3):295-298
  15. 15. Beutler BA. TLRs and innate immunity. Blood. 2009;113(7):1399-1407
  16. 16. Kersse K, Bertrand MJ, Lamkanfi M, Vandenabeele P. NOD-like receptors and the innate immune system: Coping with danger, damage and death. Cytokine & Growth Factor Reviews. 2011;22(5-6):257-276
  17. 17. Geijtenbeek TB, van Vliet SJ, Engering A, BA TH, Van Kooyk Y. Self- and nonself-recognition by C-type lectins on dendritic cells. Annual Review of Immunology. 2004;22:33-54
  18. 18. Underhill DM, Ozinsky A. Phagocytosis of microbes: Complexity in action. Annual Review of Immunology. 2002;20:825-852
  19. 19. Bahia D, Satoskar AR, Dussurget O. Editorial: Cell Signaling in host-pathogen interactions: The host point of view. Frontiers in Immunology. 2018;9:221
  20. 20. Rabinovitch M. Professional and non-professional phagocytes: An introduction. Trends in Cell Biology. 1995;5(3):85-87
  21. 21. Isberg RR, Van Nhieu GT. The mechanism of phagocytic uptake promoted by invasin-integrin interaction. Trends in Cell Biology. 1995;5(3):120-124
  22. 22. Galan JE. Salmonella interactions with host cells: Type III secretion at work. Annual Review of Cell and Developmental Biology. 2001;17:53-86
  23. 23. Greenberg S, Chang P, Silverstein SC. Tyrosine phosphorylation is required for fc receptor-mediated phagocytosis in mouse macrophages. The Journal of Experimental Medicine. 1993;177(2):529-534
  24. 24. Kruskal BA, Sastry K, Warner AB, Mathieu CE, Ezekowitz RA. Phagocytic chimeric receptors require both transmembrane and cytoplasmic domains from the mannose receptor. The Journal of Experimental Medicine. 1992;176(6):1673-1680
  25. 25. Greenberg S, Burridge K, Silverstein SC. Colocalization of F-actin and Talin during fc receptor-mediated phagocytosis in mouse macrophages. The Journal of Experimental Medicine. 1990;172(6):1853-1856
  26. 26. Gray M, Botelho RJ. Phagocytosis: Hungry, hungry cells. Methods in Molecular Biology. 2017;1519:1-16
  27. 27. Huynh KK, Kay JG, Stow JL, Grinstein S. Fusion, fission, and secretion during phagocytosis. Physiology (Bethesda). 2007;22:366-372
  28. 28. Desjardins M, Huber LA, Parton RG, Griffiths G. Biogenesis of phagolysosomes proceeds through a sequential series of interactions with the endocytic apparatus. The Journal of Cell Biology. 1994;124(5):677-688
  29. 29. Pitt A, Mayorga LS, Stahl PD, Schwartz AL. Alterations in the protein composition of maturing phagosomes. The Journal of Clinical Investigation. 1992;90(5):1978-1983
  30. 30. Joiner KA, Fuhrman SA, Miettinen HM, Kasper LH, Mellman I. Toxoplasma gondii: Fusion competence of parasitophorous vacuoles in fc receptor-transfected fibroblasts. Science. 1990;249(4969):641-646
  31. 31. Joiner KA. Vacuolar membranes surrounding intracellular pathogens: Where do they come from and what do they do? Infectious Agents and Disease. 1993;2(4):215-219
  32. 32. Joiner KA, Ganz T, Albert J, Rotrosen D. The opsonizing ligand on salmonella typhimurium influences incorporation of specific, but not azurophil, granule constituents into neutrophil phagosomes. The Journal of Cell Biology. 1989;109(6 Pt 1):2771-2782
  33. 33. Bouvier G, Benoliel AM, Foa C, Bongrand P. Relationship between phagosome acidification, phagosome-lysosome fusion, and mechanism of particle ingestion. Journal of Leukocyte Biology. 1994;55(6):729-734
  34. 34. Flannagan RS, Jaumouille V, Grinstein S. The cell biology of phagocytosis. Annual Review of Pathology. 2012;7:61-98
  35. 35. Dale DC, Boxer L, Liles WC. The phagocytes: Neutrophils and monocytes. Blood. 2008;112(4):935-945
  36. 36. Mottola G. The complexity of Rab5 to Rab7 transition guarantees specificity of pathogen subversion mechanisms. Frontiers in Cellular and Infection Microbiology. 2014;4:180
  37. 37. Cabrera M, Ungermann C. Guiding endosomal maturation. Cell. 2010;141(3):404-406
  38. 38. Peters NC, Egen JG, Secundino N, Debrabant A, Kimblin N, Kamhawi S, et al. In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies. Science. 2008;321(5891):970-974
  39. 39. Liu D, Uzonna JE. The early interaction of Leishmania with macrophages and dendritic cells and its influence on the host immune response. Frontiers in Cellular and Infection Microbiology. 2012;2:83
  40. 40. von Stebut E, Tenzer S. Cutaneous leishmaniasis: Distinct functions of dendritic cells and macrophages in the interaction of the host immune system with Leishmania major. International Journal of Medical Microbiology. 2018;308(1):206-214
  41. 41. Zenian A, Rowles P, Gingell D. Scanning electron-microscopic study of the uptake of Leishmania parasites by macrophages. Journal of Cell Science. 1979;39:187-199
  42. 42. Rotureau B, Morales MA, Bastin P, Spath GF. The flagellum-mitogen-activated protein kinase connection in trypanosomatids: A key sensory role in parasite signalling and development? Cellular Microbiology. 2009;11(5):710-718
  43. 43. Beverley SM, Turco SJ. Lipophosphoglycan (LPG) and the identification of virulence genes in the protozoan parasite Leishmania. Trends in Microbiology. 1998;6(1):35-40
  44. 44. Puentes SM, Da Silva RP, Sacks DL, Hammer CH, Joiner KA. Serum resistance of metacyclic stage Leishmania major promastigotes is due to release of C5b-9. Journal of Immunology. 1990;145(12):4311-4316
  45. 45. Davies CR, Cooper AM, Peacock C, Lane RP, Blackwell JM. Expression of LPG and GP63 by different developmental stages of Leishmania major in the sandfly Phlebotomus papatasi. Parasitology. 1990;101(Pt 3):337-343
  46. 46. Kelleher M, Moody SF, Mirabile P, Osborn AH, Bacic A, Handman E. Lipophosphoglycan blocks attachment of Leishmania major amastigotes to macrophages. Infection and Immunity. 1995;63(1):43-50
  47. 47. Pimenta PF, Saraiva EM, Sacks DL. The comparative fine structure and surface glycoconjugate expression of three life stages of Leishmania major. Experimental Parasitology. 1991;72(2):191-204
  48. 48. Talamas-Rohana P, Wright SD, Lennartz MR, Russell DG. Lipophosphoglycan from Leishmania mexicana promastigotes binds to members of the CR3, p150,95 and LFA-1 family of leukocyte integrins. Journal of Immunology. 1990;144(12):4817-4824
  49. 49. Mosser DM, Edelson PJ. Activation of the alternative complement pathway by Leishmania promastigotes: Parasite lysis and attachment to macrophages. Journal of Immunology. 1984;132(3):1501-1505
  50. 50. Blackwell JM, Ezekowitz RA, Roberts MB, Channon JY, Sim RB, Gordon S. Macrophage complement and lectin-like receptors bind Leishmania in the absence of serum. The Journal of Experimental Medicine. 1985;162(1):324-331
  51. 51. Cooper A, Rosen H, Blackwell JM. Monoclonal antibodies that recognize distinct epitopes of the macrophage type three complement receptor differ in their ability to inhibit binding of Leishmania promastigotes harvested at different phases of their growth cycle. Immunology. 1988;65(4):511-514
  52. 52. Da Silva RP, Hall BF, Joiner KA, Sacks DL. CR1, the C3b receptor, mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages. Journal of Immunology. 1989;143(2):617-622
  53. 53. Brittingham A, Morrison CJ, McMaster WR, McGwire BS, Chang KP, Mosser DM. Role of the Leishmania surface protease gp63 in complement fixation, cell adhesion, and resistance to complement-mediated lysis. Journal of Immunology. 1995;155(6):3102-3111
  54. 54. Russell DG. The macrophage-attachment glycoprotein gp63 is the predominant C3-acceptor site on Leishmania mexicana promastigotes. European Journal of Biochemistry. 1987;164(1):213-221
  55. 55. Chang KP. Leishmania donovani-macrophage binding mediated by surface glycoproteins/antigens: Characterization in vitro by a radioisotopic assay. Molecular and Biochemical Parasitology. 1981;4(1-2):67-76
  56. 56. Russell DG, Talamas-Rohana P, Zelechowski J. Antibodies raised against synthetic peptides from the Arg-Gly-asp-containing region of the Leishmania surface protein gp63 cross-react with human C3 and interfere with gp63-mediated binding to macrophages. Infection and Immunity. 1989;57(2):630-632
  57. 57. Guy RA, Belosevic M. Comparison of receptors required for entry of Leishmania major amastigotes into macrophages. Infection and Immunity. 1993;61(4):1553-1558
  58. 58. Wilson ME, Pearson RD. Roles of CR3 and mannose receptors in the attachment and ingestion of Leishmania donovani by human mononuclear phagocytes. Infection and Immunity. 1988;56(2):363-369
  59. 59. Chakraborty R, Chakraborty P, Basu MK. Macrophage mannosyl fucosyl receptor: Its role in invasion of virulent and avirulent L. donovani promastigotes. Bioscience Reports. 1998;18(3):129-142
  60. 60. Rizvi FS, Ouaissi MA, Marty B, Santoro F, Capron A. The major surface protein of Leishmania promastigotes is a fibronectin-like molecule. European Journal of Immunology. 1988;18(3):473-476
  61. 61. Brittingham A, Chen G, McGwire BS, Chang KP, Mosser DM. Interaction of Leishmania gp63 with cellular receptors for fibronectin. Infection and Immunity. 1999;67(9):4477-4484
  62. 62. Culley FJ, Harris RA, Kaye PM, McAdam KP, Raynes JG. C-reactive protein binds to a novel ligand on Leishmania donovani and increases uptake into human macrophages. Journal of Immunology. 1996;156(12):4691-4696
  63. 63. Campos MA, Almeida IC, Takeuchi O, Akira S, Valente EP, Procopio DO, et al. Activation of toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. Journal of Immunology. 2001;167(1):416-423
  64. 64. Kropf P, Freudenberg MA, Modolell M, Price HP, Herath S, Antoniazi S, et al. Toll-like receptor 4 contributes to efficient control of infection with the protozoan parasite Leishmania major. Infection and Immunity. 2004;72(4):1920-1928
  65. 65. Holm A, Tejle K, Magnusson KE, Descoteaux A, Rasmusson B. Leishmania donovani lipophosphoglycan causes periphagosomal actin accumulation: Correlation with impaired translocation of PKCalpha and defective phagosome maturation. Cellular Microbiology. 2001;3(7):439-447
  66. 66. Channon JY, Roberts MB, Blackwell JM. A study of the differential respiratory burst activity elicited by promastigotes and amastigotes of Leishmania donovani in murine resident peritoneal macrophages. Immunology. 1984;53(2):345-355
  67. 67. Assreuy J, Cunha FQ , Epperlein M, Noronha-Dutra A, O’Donnell CA, Liew FY, et al. Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major. European Journal of Immunology. 1994;24(3):672-676
  68. 68. Ilg T, Stierhof YD, McConville MJ, Overath P. Purification, partial characterization and immunolocalization of a proteophosphoglycan secreted by Leishmania mexicana amastigotes. European Journal of Cell Biology. 1995;66(2):205-215
  69. 69. Ramet M, Pearson A, Manfruelli P, Li X, Koziel H, Gobel V, et al. Drosophila scavenger receptor CI is a pattern recognition receptor for bacteria. Immunity. 2001;15(6):1027-1038
  70. 70. Gomes IN, Palma LC, Campos GO, Lima JG, TF DEA, JP DEM, et al. The scavenger receptor MARCO is involved in Leishmania major infection by CBA/J macrophages. Parasite Immunology. 2009;31(4):188-198
  71. 71. Minero MA, Chinchilla M, Guerrero OM, Castro A. Infection of skin fibroblasts in animals with different levels of sensitivity to Leishmania infantum and Leishmania mexicana (Kinetoplastida: Trypanosomatidae). Revista de Biología Tropical. 2004;52(1):261-267
  72. 72. Rittig MG, Bogdan C. Leishmania-host-cell interaction: Complexities and alternative views. Parasitology Today. 2000;16(7):292-297
  73. 73. Bogdan C, Donhauser N, Doring R, Rollinghoff M, Diefenbach A, Rittig MG. Fibroblasts as host cells in latent leishmaniosis. The Journal of Experimental Medicine. 2000;191(12):2121-2130
  74. 74. Holbrook TW, Palczuk NC. Leishmania in the chick embryo. IV. Effects of embryo age and hatching, and behavior of L. donovani in cultures of chick fibroblasts. Experimental Parasitology. 1975;37(3):398-404
  75. 75. Cavalcante-Costa VS, Costa-Reginaldo M, Queiroz-Oliveira T, Oliveira ACS, Couto NF, Dos Anjos DO, et al. Leishmania amazonensis hijacks host cell lysosomes involved in plasma membrane repair to induce invasion in fibroblasts. Journal of Cell Science. 2019;132(6):1-16
  76. 76. Fernandes MC, Cortez M, Flannery AR, Tam C, Mortara RA, Andrews NW. Trypanosoma cruzi subverts the sphingomyelinase-mediated plasma membrane repair pathway for cell invasion. The Journal of Experimental Medicine. 2011;208(5):909-921
  77. 77. Corrotte M, Castro-Gomes T. Lysosomes and plasma membrane repair. Current Topics in Membranes. 2019;84:1-16
  78. 78. Vergne I, Chua J, Singh SB, Deretic V. Cell biology of mycobacterium tuberculosis phagosome. Annual Review of Cell and Developmental Biology. 2004;20:367-394
  79. 79. Jutras I, Desjardins M. Phagocytosis: at the crossroads of innate and adaptive immunity. Annual Review of Cell and Developmental Biology. 2005;21:511-527
  80. 80. Veras PS, de Chastellier C, Rabinovitch M. Transfer of zymosan (yeast cell walls) to the parasitophorous vacuoles of macrophages infected with Leishmania amazonensis. The Journal of Experimental Medicine. 1992;176(3):639-646
  81. 81. Alexander J, Russell DG. The interaction of Leishmania species with macrophages. Advances in Parasitology. 1992;31:175-254
  82. 82. De Souza LS, Lang T, Prina E, Hellio R, Antoine JC. Intracellular Leishmania amazonensis amastigotes internalize and degrade MHC class II molecules of their host cells. Journal of Cell Science. 1995;108(Pt 10):3219-3231
  83. 83. Desjardins M, Descoteaux A. Survival strategies of Leishmania donovani in mammalian host macrophages. Research in Immunology. 1998;149(7-8):689-692
  84. 84. Tait A, Sacks DL. The cell biology of parasite invasion and survival. Parasitology Today. 1988;4(8):228-234
  85. 85. Batista MF, Najera CA, Meneghelli I, Bahia D. The parasitic intracellular lifestyle of trypanosomatids: Parasitophorous vacuole development and survival. Frontiers in Cell and Development Biology. 2020;8:396
  86. 86. Chang KP, Dwyer DM. Multiplication of a human parasite (Leishmania donovani) in phagolysosomes of hamster macrophages in vitro. Science. 1976;193(4254):678-680
  87. 87. Rabinovitch M, Topper G, Cristello P, Rich A. Receptor-mediated entry of peroxidases into the parasitophorous vacuoles of macrophages infected with Leishmania Mexicana amazonensis. Journal of Leukocyte Biology. 1985;37(3):247-261
  88. 88. Antoine JC, Prina E, Jouanne C, Bongrand P. Parasitophorous vacuoles of Leishmania amazonensis-infected macrophages maintain an acidic pH. Infection and Immunity. 1990;58(3):779-787
  89. 89. Desjardins M, Descoteaux A. Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan. The Journal of Experimental Medicine. 1997;185(12):2061-2068
  90. 90. Antoine JC, Prina E, Lang T, Courret N. The biogenesis and properties of the parasitophorous vacuoles that harbour Leishmania in murine macrophages. Trends in Microbiology. 1998;6(10):392-401
  91. 91. Gagnon E, Duclos S, Rondeau C, Chevet E, Cameron PH, Steele-Mortimer O, et al. Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages. Cell. 2002;110(1):119-131
  92. 92. Canton J, Ndjamen B, Hatsuzawa K, Kima PE. Disruption of the fusion of Leishmania parasitophorous vacuoles with ER vesicles results in the control of the infection. Cellular Microbiology. 2012;14(6):937-948
  93. 93. Dermine JF, Scianimanico S, Prive C, Descoteaux A, Desjardins M. Leishmania promastigotes require lipophosphoglycan to actively modulate the fusion properties of phagosomes at an early step of phagocytosis. Cellular Microbiology. 2000;2(2):115-126
  94. 94. Verma JK, Rastogi R, Mukhopadhyay A. Leishmania donovani resides in modified early endosomes by upregulating Rab5a expression via the downregulation of miR-494. PLoS Pathogens. 2017;13(6):e1006459
  95. 95. Courret N, Frehel C, Gouhier N, Pouchelet M, Prina E, Roux P, et al. Biogenesis of Leishmania-harbouring parasitophorous vacuoles following phagocytosis of the metacyclic promastigote or amastigote stages of the parasites. Journal of Cell Science. 2002;115(Pt 11):2303-2316
  96. 96. Veras PST, de Menezes JPB, Dias BRS. Deciphering the role played by autophagy in Leishmania infection. Frontiers in Immunology. 2019;10:2523
  97. 97. Lang T, Hellio R, Kaye PM, Antoine JC. Leishmania donovani-infected macrophages: Characterization of the parasitophorous vacuole and potential role of this organelle in antigen presentation. Journal of Cell Science. 1994;107(Pt 8):2137-2150
  98. 98. Veras PS, de Chastellier C, Moreau MF, Villiers V, Thibon M, Mattei D, et al. Fusion between large phagocytic vesicles: Targeting of yeast and other particulates to phagolysosomes that shelter the bacterium Coxiella burnetii or the protozoan Leishmania amazonensis in Chinese hamster ovary cells. Journal of Cell Science. 1994;107(Pt 11):3065-3076
  99. 99. Veras PS, Topilko A, Gouhier N, Moreau MF, Rabinovitch M, Pouchelet M. Fusion of Leishmania amazonensis parasitophorous vacuoles with phagosomes containing zymosan particles: Cinemicrographic and ultrastructural observations. Brazilian Journal of Medical and Biological Research. 1996;29(8):1009-1018
  100. 100. Wilson J, Huynh C, Kennedy KA, Ward DM, Kaplan J, Aderem A, et al. Control of parasitophorous vacuole expansion by LYST/beige restricts the intracellular growth of Leishmania amazonensis. PLoS Pathogens. 2008;4(10):e1000179
  101. 101. Okuda K, Tong M, Dempsey B, Moore KJ, Gazzinelli RT, Silverman N. Leishmania amazonensis engages CD36 to drive Parasitophorous vacuole maturation. PLoS Pathogens. 2016;12(6):e1005669
  102. 102. Pessoa CC, Reis LC, Ramos-Sanchez EM, Orikaza CM, Cortez C, de Castro Levatti EV, et al. ATP6V0d2 controls Leishmania parasitophorous vacuole biogenesis via cholesterol homeostasis. PLoS Pathogens. 2019;15(6):e1007834
  103. 103. Ribeiro-Gomes FL, Otero AC, Gomes NA, Moniz-De-Souza MC, Cysne-Finkelstein L, Arnholdt AC, et al. Macrophage interactions with neutrophils regulate Leishmania major infection. Journal of Immunology. 2004;172(7):4454-4462
  104. 104. Afonso L, Borges VM, Cruz H, Ribeiro-Gomes FL, DosReis GA, Dutra AN, et al. Interactions with apoptotic but not with necrotic neutrophils increase parasite burden in human macrophages infected with Leishmania amazonensis. Journal of Leukocyte Biology. 2008;84(2):389-396
  105. 105. van Zandbergen G, Solbach W, Laskay T. Apoptosis driven infection. Autoimmunity. 2007;40(4):349-352
  106. 106. Laskay T, van Zandbergen G, Solbach W. Neutrophil granulocytes--Trojan horses for Leishmania major and other intracellular microbes? Trends in Microbiology. 2003;11(5):210-214
  107. 107. Love DC, Mentink Kane M, Mosser DM. Leishmania amazonensis: The phagocytosis of amastigotes by macrophages. Experimental Parasitology. 1998;88(3):161-171
  108. 108. Kane MM, Mosser DM. Leishmania parasites and their ploys to disrupt macrophage activation. Current Opinion in Hematology. 2000;7(1):26-31
  109. 109. Wanderley JL, Moreira ME, Benjamin A, Bonomo AC, Barcinski MA. Mimicry of apoptotic cells by exposing phosphatidylserine participates in the establishment of amastigotes of Leishmania (L) amazonensis in mammalian hosts. Journal of Immunology. 2006;176(3):1834-1839
  110. 110. Real F, Florentino PT, Reis LC, Ramos-Sanchez EM, Veras PS, Goto H, et al. Cell-to-cell transfer of Leishmania amazonensis amastigotes is mediated by immunomodulatory LAMP-rich parasitophorous extrusions. Cellular Microbiology. 2014;16(10):1549-1564
  111. 111. Bray RS, Heikal B, Kaye PM, Bray MA. The effect of parasitization by Leishmania mexicana mexicana on macrophage function in vitro. Acta Tropica. 1983;40(1):29-38
  112. 112. De Almeida MC, Cardoso SA, Barral-Netto M. Leishmania (Leishmania) chagasi infection alters the expression of cell adhesion and costimulatory molecules on human monocyte and macrophage. International Journal for Parasitology. 2003;33(2):153-162
  113. 113. Carvalhal DG, Barbosa A Jr, D'El-Rei Hermida M, Clarencio J, Pinheiro NF Jr, Veras PS, et al. The modelling of mononuclear phagocyte-connective tissue adhesion in vitro: Application to disclose a specific inhibitory effect of Leishmania infection. Experimental Parasitology. 2004;107(3-4):189-199
  114. 114. Pinheiro NF Jr, Hermida MD, Macedo MP, Mengel J, Bafica A, dos-Santos WL. Leishmania infection impairs beta 1-integrin function and chemokine receptor expression in mononuclear phagocytes. Infection and Immunity. 2006;74(7):3912-3921
  115. 115. Figueira CP, Carvalhal DG, Almeida RA, Hermida M, Touchard D, Robert P, et al. Leishmania infection modulates beta-1 integrin activation and alters the kinetics of monocyte spreading over fibronectin. Scientific Reports. 2015;5:12862
  116. 116. Rocha MI, Dias F, Resende M, Sousa M, Duarte M, Tomas AM, et al. Leishmania infantum enhances migration of macrophages via a phosphoinositide 3-kinase gamma-dependent pathway. ACS Infect Dis. 2020;6(7):1643-1649
  117. 117. Bogdan C. Macrophages as host, effector and immunoregulatory cells in leishmaniasis: Impact of tissue micro-environment and metabolism. Cytokine X. 2020;2(4):100041
  118. 118. Rossi M, Fasel N. How to master the host immune system? Leishmania parasites have the solutions! International Immunology. 2018;30(3):103-111
  119. 119. Gantt KR, Goldman TL, McCormick ML, Miller MA, Jeronimo SM, Nascimento ET, et al. Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi. Journal of Immunology. 2001;167(2):893-901
  120. 120. Murray HW, Rubin BY, Rothermel CD. Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine. The Journal of Clinical Investigation. 1983;72(4):1506-1510
  121. 121. Douvas GS, Looker DL, Vatter AE, Crowle AJ. Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria. Infection and Immunity. 1985;50(1):1-8
  122. 122. Carneiro MB, Vaz LG, Afonso LCC, Horta MF, Vieira LQ. Regulation of macrophage subsets and cytokine production in leishmaniasis. Cytokine. 2021;147:155309

Written By

Patrícia Sampaio Tavares Veras, Thiago Castro-Gomes and Juliana Perrone Bezerra de Menezes

Submitted: 16 February 2022 Reviewed: 18 May 2022 Published: 23 June 2022